None
Quote | iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT)
Last: | $92.92 |
---|---|
Change Percent: | 0.46% |
Open: | $93.04 |
Close: | $92.92 |
High: | $93.16 |
Low: | $92.82 |
Volume: | 33,723,156 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT)
2024-07-19 09:52:00 ET Summary The Federal Reserve is widely expected to start cutting interest rates at the Sep. 18 FOMC meeting, but the debate is turning to how far the central bank will trim its policy rate once the easing begins. The true neutral rate is unobservable, and so ...
2024-07-19 04:20:00 ET Summary The ECB decided to keep rates on hold as expected, and markets received little forward guidance. We see a continuation of the global macro trend for steeper curves, driven by the prospect of future cuts. We saw something similar for the Gilt curv...
Message Board Posts | iShares 20+ Year Treasury Bond ETF (NASDAQ:TLT)
Subject | By | Source | When |
---|---|---|---|
PR Aug. 22, 2019 | frebeach | investorshub | 08/29/2019 4:34:56 PM |
PR July 31st, 2019. | frebeach | investorshub | 08/29/2019 4:31:12 PM |
Theralase Granted Notice of Acceptance for PhotoDynamic Compounds | frebeach | investorshub | 05/28/2019 3:54:41 PM |
Theralase Commences Phase II NMIBC Clinical Study | lonade | investorshub | 04/25/2019 11:32:52 AM |
Lightning Strikes Twice: A SECOND Patient Cancer-Free After | lonade | investorshub | 04/09/2019 12:33:43 PM |
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...